The MyPal4Kids study gets underway!
The MyPal project has been recruiting patients at our Clinical Department since January 2021. The study is aimed at young patients between the ages of 6 and 17 who are undergoing treatment for cancer at our Clinical Department.
MyPal is an EU-funded project that aims to improve the quality of life of children, adolescents and adults with cancer and their families by improving patient involvement in treatment with the help of an app.
MyPal4Kids aims to enable children and young people with cancer and their families to more accurately record symptoms of their disease and communicate them more effectively to their healthcare providers. By providing this information in a timely and comprehensive manner during the course of the disease, the potential for the application of patient-centered and integrated medical care involving all relevant medical caregivers (e.g. oncologists, specialists, psychologists, nurses) is strengthened. Participation is completely voluntary. The only requirement is the possession and use of an internet-enabled smartphone or tablet.
- Further information can be found on the MyPal project page.
If you have any questions about MyPal, you can contact us at any time!
Simply send us an e-mail at pao.mypal@mh-hannover.de.
Or give us a call: +49 511 532-6720.
Information for patients
Here on this page you will find the most important links to find out about our extensive range of medical services. Our clinical work is always closely linked to our research work. This enables us to better understand how cancers develop in children and adolescents and to help improve treatment options. If you have any questions, please feel free to contact us at any time.
Get in touch with us!
About cancer therapy in children
In Germany, more than nine out of ten children or adolescents with cancer are treated according to standardized, up-to-date treatment plans, which are regularly adapted to the latest international scientific findings by the Society for Pediatric Oncology and Hematology (GPOH). Thanks to these standardized treatment plans with quality-assured procedures, the overall cure rates for children and adolescents with cancer in Germany have increased to 75%. They are therefore among the highest in industrialized countries.
This success requires age-appropriate and professional treatment that is gentle and effective at the same time, which absolutely requires the close cooperation of a treatment team consisting of pediatric oncologists, radiotherapists, surgeons, pathologists, child psychologists, nursing staff, scientists and many others. This is why the treatment of children and adolescents with cancer in Germany takes place in specialized centers, i.e. large Clinical Departments, where all the aforementioned members of a treatment team are available. The Pediatric Oncology Department at the MHH is one such Clinical Department.